‫004ف‬ amino acids (aa) of the N terminus, followed by a domain (300 aa) related to LAOBP (lysine, arginine, ornithine binding protein), which is split in two parts, one preceding TM1 and the other being part of the extracellular loop between TM3 and TM4 (see Figure 1A ). 
but biologically relevant sequence similarities (Altschul particular, no alignment of the amino-terminal domain of any of the NR2 subunits with LIVBP or LBP has been et al., 1997). With the first 380 residues of the rat NMDA NR2A subunit used as the query sequence in a Psireported. The major difficulty in performing such alignments is that the percent sequence identity observed BLAST database search, a large number of sequences with E-value better than threshold (fixed to 10 Ϫ3 ; see between LIVBP and the amino-terminal domain of NR1 or any of the NR2 subunit (10%-15%) is clearly under Experimental Procedures) appeared. They belong to the following families: ionotropic glutamate receptors (NMDA, the limit (25%-30% sequence identity) usually considered as reliable for standard 1D sequence alignments. AMPA, and kainate receptors), orphan glutamate receptors (the ␦ subunits), the In an attempt to identify residues implicated in the highcase, similar hydrophobic signatures could be detected, the resemblance being most striking in the first ‫052ف‬ affinity Zn inhibition, we recently performed a point mutagenesis scan through the LIVBP-like domain of the residues (data not shown), where the pattern of alternating strongly hydrophobic ␤ strands and amphipathic ␣ NR2A subunit (Fayyazuddin et al., 2000) . Of the 47 positions mutated, only four residues, two histidines, one helices characteristic of LIVBP is conserved. This putatively conserved secondary structure pattern was used lysine, and one glutamate (H44, H128, K233, E266), generated a "strong" phenotype when mutated individually to constrain the alignment of the NR2 N-terminal regions with LIVBP (Figure 2 The relatively well-conserved hydrophobic patterns of and vertebrate metabotropic receptors (for GABA, glutamate and calcium) on the other hand. Residues known the first two-thirds of the analyzed sequences produced alignments with only a few gaps that were intentionally (from crystal structures of the different periplasmic bacterial proteins) or proposed (from functional studies of introduced in loops between secondary structure elements. The situation was much more complicated in the the different metabotropic receptors) to contact the ligand have been highlighted (blue boxes). This multiplelast third of the analyzed sequences. In this latter region, many gaps had to be included in the alignments in order sequence alignment analysis reveals that the residues directly participating in the agonist binding site are disto match the detected hydrophobic clusters from LIVBP with those from the NR2 subunits. Clearly, the degree tributed in a characteristic pattern. Indeed, while they are spread throughout the LIVBP-like domains, they all of similarity (if any) between the hydrophobic clusters in this region is weak, rendering the positioning of putative cluster (with very few exceptions) in a few discrete loops located between secondary structure elements. In that homologous hydrophobic clusters rather uncertain. The fact that the last third of LIVBP contains only small ␤ respect, it is remarkable that, despite the wide variety of ligands (e.g., amino acids, monosaccharides, ions, strands located at the periphery of the core of the central ␤ sheet suggests that this region is less important as etc.) recognized by these protein families, the different LIVBP-like domains share common regions participating controlling the fold than the rest of the protein and therefore could be subjected to a higher structural divergence in ligand binding. Strikingly, the four residues that we previously identified as controlling Zn binding in NR2A all during evolution.
The proposed sequence alignment also shows idenlocalize to such regions (loop ␤1/␣1 for H44, loop ␤4/␣4 for H128, loop ␤8/␣8 for K233, and loop ␤9/␣9 for E266; tity clusters between the NR2 N-terminal regions and LIVBP (see bold letters in Figure 2 ). Such clusters are green boxes). . In contrast to the NR2A-D102A and NR2A-D105A mutations, the NR2A-D103A mutation only ␤6/␣6) and E308 (region ␣11). However, we previously showed that neither mutation D182S nor E308Q signifimoderately decreased Zn sensitivity (see Table 1 controlling Zn inhibition was confirmed by carrying out a series of mutations in which the critical residues were Similar results were obtained with the NR2A-D105A mutation (see Table 1 ). Full Zn dose inhibition curves were individually replaced by residues usually found in Zn binding sites (C, H, E, and D; see Glusker, 1991). As obtained for the NR2A-D102A mutation ( Figure 4B) , showing a 500-fold increase of IC 50 compared to the shown in Table 1 , most of the substitutions tested (with the noticeable exception of the E266 position) displayed wild-type receptors. The observed shift in Zn sensitivity sion), the scores obtained were in the range of scores 
High-Affinity Zn inhibition
The overall secondary and tertiary structure organizations are illustrated in Figure 5A and, as expected from Figure 5B displays the six residues identified as con- section) so that the critical residues from lobe I and lobe II participate together to coordinate Zn.
Experimental Validation of the 3D Model similar phenotypes as the A or S substitutions with
As a first step, we reexamined in our model each of the strongly reduced Zn affinity. We also tried to reconstitute mutations (other than the "strong" mutations) that we an artificial but functional high-affinity Zn binding site had previously tested for Zn sensitivity (most of them by simultaneously replacing multiple critical residues or being charged polar residues, histidines, or cysteines; by swapping pairwise critical residues. Once again, each see Table 1 electrostatic mechanism since, in our model, this resilocalized at the "entrance" of the cleft, and (3) residues with an ␣ carbons or side chain close to the ␣ carbon due is localized in ␣8 at a distance of more than 20 Å from the cleft. However, as we showed previously (see or side chain of one (or more) of the critical residues. Group (1) mutations aimed at testing the idea that Fayyazuddin et al., 2000), this mutation is not specific for the Zn modulation and could affect gating at a point buried hydrophobic residues participating in multiple hydrophobic contacts are essential for the proper folddistant from the Zn binding step itself. Finally, only very few positions show functional phenotypes difficult to ing of the domain. Among the residues located in ␤ strands in the hydrophobic nucleus at positions homoloreconcile with their position in the model. This is particularly the case for the D234 position, which shows unalgous or close to the topohydrophobic residues found in LIVBP (see Figure 2) , we chose L98, V173, and W255 tered Zn sensitivity (when mutated to an alanine), whereas its location (with its side chain close to K233 (in ␤3, lobe I and ␤6 and ␤9, lobe II, respectively). We replaced them individually by an aspartate, a residue and E266) suggests that it could aid in the correct positioning of these two critical residues. that is rarely found in regular secondary structures but has a strong propensity to participate in the formation In a second step of the validation of the model, we generated a series of point mutations targeted to resiof loops (see Callebaut et al., 1997). In agreement with their proposed role in the correct folding of the domain, dues chosen for their specific locations in the model hoping to produce altered phenotypes in a predictable all three mutations (L98D, V173D, and W255D) yielded nonfunctional receptors. The lack of functional expression way. To maximize the contribution of such an approach, we selected nine residues that were scattered at differwas not studied further but could result from improper subunit assembly or perturbed cellular trafficking. ent locations in the structure (lobe I, lobe II, hinge). These residues were classified in three groups, according to Group (2) mutations aimed at testing the idea that charged residues localized at the "entrance" of the cleft their location in the model: (1) buried residues of the hydrophobic central core, (2) exposed charged residues provide an electrostatic environment that may influence the efficiency with which Zn binds to its site. The two each selected residue to an alanine in order to verify that such mutants differed from "strong" mutants. This positions D78 (in lobe I) and D207 (in lobe II) were good candidates to play such a role (see above). We mutated was indeed observed (see Figure 6B and Table 2 ). We then mutated each residue to an arginine (except for these two residues with either charge conservation (substitution by an E) or charge inversion (substitution by a D103 which was mutated to K). As shown in Figure 6B and Table 2 , such mutations produced receptors with K). As shown in Figure 6A and Table 2, as the charge at 78 or 207 becomes more positive (D → A → K), the drastically reduced Zn inhibition. In fact, the magnitude of the effects were comparable to those observed with mutant receptors become progressively less sensitive to Zn inhibition. As expected for an electrostatic mecha-A or S mutations at the critical residues ("strong" mutations; see Table 1 ). nism, the D → E substitution at position 207 resulted in a phenotype close to wild type. However, this was not the case at the 78 position, indicating clearly that effects Zn Binding Prevents MTSET Accessibility to Cysteines Engineered in the Back other than simple electrostatics are involved.
Group (3) mutants aimed at testing the idea that resiof the Cleft
Crystallographic studies of a number of periplasmic dues located in close proximity of the critical residues should have a profound effect on Zn inhibition when binding proteins have revealed that these proteins can adopt either an "open" or a "closed" conformation demutated to a positively charged residue. Residues D103, S259, S262, and Y281 were chosen for that purpose. pending on the absence or presence of the ligand. In the "closed" conformation, the ligand is nestled in the D103 (in lobe I) is adjacent to the "strong" positions D102 and D105 (see Figure 3) , S259 and S262 (in lobe interlobe cleft and contacts residues from both lobes.
In the "open" ligand-free conformation, the two lobes are II) both localize in the ␤9/␣9 loop known to be implicated in ligand recognition in a number of LIVBP-like domains further apart, rendering the cleft between the lobes more open and solvent accessible. The ligand appears there-(see Figure 3) , and Y281 (in the hinge) projects its side chain toward the cleft close to H44. We first mutated fore to induce a hinge-bending motion (also called the main that produce large shifts in Zn sensitivity when tering the ligand (see Quiocho and Ledvina, 1996) . Thus, overall, our data strongly support the hypothesis that mutated to an A or an S but also to most other substitutions tested (see Table 1 ). Second, the large effects H44, D102, D105, H128, K233, and E266 directly contribute to the formation of the high-affinity Zn binding site induced by these mutations are specific for the highaffinity Zn inhibition (see Fayyazuddin et al. [2000] and either by intimately participating in Zn recognition or by directly coordinating it. unpublished data for D102). Third, the nature of the side chain (carboxyl groups of D102, D105, and E266;
The location of the putative Zn binding residues in the modeled structure, two groups of residues facing each imidazole groups of H44 and H128) is compatible with direct Zn coordination (for the amino group of K233 other across the cleft and separated by ‫41ف‬ Å (see Figure 8) . Accordingly, the enhanced Zn sensitivity observed with the Y281A these receptors mediate subtype-specific subunit assembly (Leuschner and Hoch, 1999) and that isolated or Y281C mutations (see Table 2 
